UnitedHealth Group, Morgan Stanley rise; PNC Financial, Live Nation fall, Tuesday, 4/16/2024
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Tuesday:
Intra-Cellular Therapies Inc., up $15.08 to $79.84.
The biopharmaceutical company made an encouraging update on its potential treatment for a depressive disorder.
UnitedHealth Group Inc., up $23.26 to $468.89.
The health insurance giant beat Wall Street’s first-quarter earnings and revenue forecasts.
Morgan Stanley, up $2.15 to $89.14.
The investment bank’s first-quarter earnings and revenue beat analysts’ forecasts.
Live Nation Entertainment Inc., down $7.56 to $92.21.
The U.S. Justice Department is reportedly preparing an antitrust lawsuit against the ticket seller and concert promoter.
Barrick Gold Corp., down 89 cents to $16.48.
Investors were disappointed by the gold and copper miner’s first-quarter production.
PNC Financial Services Group Inc., down $3.02 to $146.54.
Related articles
Horoscope today: Daily guide to what the stars have in store for YOU
'Shinrin-Yoku' is the Japanese term for a 'forest bath'. It's the practice of immersing in nature as2024-04-30Ruud advances to Barcelona semis after beating Arnaldi in straight sets
BARCELONA, Spain (AP) — Casper Ruud beat Matteo Arnaldi in straight sets to advance to the semifinal2024-04-30Ukraine, Israel aid bill on track as House pushes toward votes
WASHINGTON (AP) — With rare bipartisan momentum, the House pushed ahead Friday on a foreign aid pack2024-04-30Olympic organizers unveil strategy for using artificial intelligence in sports
LONDON (AP) — Olympic organizers unveiled their strategy Friday to use artificial intelligence in sp2024-04-30British and Irish officials meet as tensions rise over what to do with asylum seekers
LONDON (AP) — British and Irish officials met Monday as tensions rise over the movement of asylum se2024-04-30NOT REAL NEWS: A look at what didn't happen this week
A roundup of some of the most popular but completely untrue stories and visuals of the week. None of2024-04-30
atest comment